1.

Record Nr.

UNINA9910453301503321

Titolo

Byron's ghosts : the spectral, the spiritual and the supernatural / / edited by Gavin Hopps

Pubbl/distr/stampa

Liverpool : , : Liverpool University Press, , 2013

ISBN

1-78138-092-9

1-78138-556-4

Descrizione fisica

1 online resource (257 p.)

Collana

Liverpool English texts and studies ; ; 62

Altri autori (Persone)

HoppsGavin

Disciplina

821.7

Soggetti

Ghosts

Occultism

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Cover; Half-title; Title page; Copyright page; Dedication; Contents; Acknowledgements; Texts and Abbreviations; Introduction; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Afterword; Bibliography; Notes on Contributors; Index

Sommario/riassunto

Byron is rarely thought of as a spiritual writer. However, as this bold new collection shows, this is the result of an impoverished notion of the 'spiritual' and a reflection of biased priorities in Romantic studies. Reflecting on the poet's claim that 'immaterialism's a serious matter', this interdisciplinary collection of essays, from British and American scholars, calls into question the prevailing 'materialist' consensus, and offers a fresh and theoretically inflected reading of Byron's poetry.Byron's Ghosts is the first book-length examination of spectrality in Byron's work. It is on the



2.

Record Nr.

UNINA9910508448003321

Titolo

Pharmacology of the WNT Signaling System / / edited by Gunnar Schulte, Pawel Kozielewicz

Pubbl/distr/stampa

Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021

ISBN

3-030-85499-X

Edizione

[1st ed. 2021.]

Descrizione fisica

1 online resource (420 pages)

Collana

Handbook of Experimental Pharmacology, , 1865-0325 ; ; 269

Disciplina

572.64

Soggetti

Pharmacology

Physiology

Oncology

Neurosciences

Developmental biology

Neuroscience

Developmental Biology and Stem Cells

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

Pharmacological thinking in WNT signaling -- Controlling WNT Signaling Specificity and implications for targeting WNTs pharmacologically -- WNTs on exosomes -- Strategies to target LRPs in WNT signaling -- Targeting the receptor tyrosine kinase ROR1 by small molecules -- Assessing WNT binding and Frizzled activation employing genetically encoded, biophysical sensors -- Disheveled proteins as crucial mediators of WNT signaling -- Destruction complex and regulation of CTNNB1 -- Strategies to therapeutically target WNT/PCP like signaling in disease -- Mining natural compounds to target WNT signaling - from mushrooms to corals -- FZD7 as a therapeutic target in intestinal cancer -- Targeting oncogenic WNT signaling with WNT derived peptides -- Targeting WNT signaling in lung pathology -- The role of WNT signaling in osteoarthritis and the therapeutic potential of its pharmacological targeting -- WNT signaling in Alzheimers disease and other neurodegenerative disorders - opportunities for therapy? -- Targeting WNT signaling as a risk.



Sommario/riassunto

This book reflects the state of the art of our understanding of the WNT signaling system, which comprises a network of signaling pathways initiated by the secreted WNT lipoglycoproteins, which are crucial for embryonal development, stem cell regulation, tissue homeostasis and repair. Dysfunction of this evolutionarily conserved signaling system leads to many diseases including developmental disorders, diverse forms of cancer, fibrosis, neurodegenerative disease and many more. The WNT signaling system is built upon 19 mammalian, secreted WNT lipoglycoproteins that interact with a plethora of distinct receptors, such as the G protein-coupled receptors called Frizzleds (FZD1-10), LDL receptor-like proteins (LRP5/6), receptor tyrosine kinases (ROR1, 2, RYK and PTK7). In addition, WNT pathways are tightly regulated by many secreted and cell-intrinsic negative regulators, such as soluble FZD-related proteins (SFRPs), Dickkopfs (DKKs), WNT-inhibitory proteins, TIKI, RNF43 and more. Understanding the basic mechanism in terms of receptor-ligand interaction, receptor selectivity, signal initiation and desensitization remain poorly understood, even though substantial advances have been made the recent years. Due to the involvement of the WNT signaling system in human disease, it appears obvious to target diverse branches pharmacologically and therapeutically. However, given the complexity of the system and its importance for stem cell regulation and tissue maintenance, therapy comes with obvious risks for severe side effects. The field is addressing the challenge to identify suitable targets and selective compounds for therapy allowing disease-selective therapeutic effects and balancing unwanted side effects. This book summarizes the current understanding of the basic and applied pharmacology in the WNT signaling system and bridges disciplines such as pharmacology, physiology, neurosciences, oncology and drug development.